Drug Hypersensitivity Reactions

Classification and Pathophysiology

• Drug hypersensitivity reactions are primarily classified into two main types based on the timing of onset: immediate reactions occurring within 1 hour of drug administration and delayed reactions occurring more than 1 hour after administration 1, 2
• Immediate reactions typically occur within 1 hour of drug administration and are often IgE-mediated (Type I), though non-IgE mediated mechanisms can also cause immediate reactions 1, 3
• Histamine is released within 5 minutes of mast cell activation and remains elevated for 15-60 minutes, causing vasodilation, increased vascular permeability, and smooth muscle contraction 4
• Clinical manifestations of immediate reactions include urticaria, pruritus, flushing, angioedema, rhinorrhea, bronchospasm, hypotension, tachycardia, and in severe cases, anaphylaxis 4

Epidemiology

• Immediate reactions to low-osmolar contrast media and iso-osmolar contrast media occur in 0.3% to 1.4% of injections, with severe reactions being uncommon (0.005% to 0.06%) 1, 3

Delayed Reactions

• Delayed reactions occur more than 1 hour after drug administration and can develop at any time, commonly after many days 5, 2
• These reactions are often associated with T-cell-dependent mechanisms (Type IV) 5
• Common clinical presentations of delayed reactions include maculopapular exanthema, drug reaction with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN) 2

Diagnostic Considerations

• For immediate reactions, serum tryptase, plasma histamine, and urinary histamine metabolites can aid diagnosis 2, 4
• Skin testing is more likely to be positive in severe immediate reactions, particularly life-threatening ones with cardiovascular symptoms 1

Management Approach

• For immediate reactions, especially anaphylaxis, epinephrine is the first-line treatment (0.01 mg/kg intramuscularly in the mid-outer thigh) 4
• For delayed reactions, immediate discontinuation of the suspected culprit drug is essential, along with topical corticosteroids and oral antihistamines for mild to moderate reactions 2
• Systemic corticosteroids and specialized care are recommended for severe delayed reactions like SJS/TEN and DRESS 2

Common Pitfalls and Caveats

• Delayed administration of epinephrine in anaphylaxis increases morbidity and mortality 4
• Beta-adrenergic blockers and angiotensin-converting enzyme inhibitors can increase the risk of severe anaphylactic reactions and reduce epinephrine effectiveness 4
• Observation periods should be considered after treating anaphylactic reactions due to the risk of biphasic reactions, especially in patients with initially severe symptoms 5

Timeframe for Developing Drug Allergy to Prozac (Fluoxetine)

Introduction to Drug Allergy Timing

• Drug allergies to Prozac (fluoxetine) typically develop between 1-6 weeks after starting the medication, with the majority of delayed hypersensitivity reactions occurring early in the second week of treatment 6, 7

Timing Based on Reaction Type

• Occur within 1-6 hours after drug administration, these are rare immediate reactions 8
• Develop more than 1 hour after initial drug administration, but commonly manifest after many days, and are T-cell mediated (Type IV hypersensitivity) 6
• The majority occur early in the second week after initiating therapy 6

Clinical Presentation and Diagnosis

• The American Academy of Pediatrics notes that skin rash and pruritus may appear after several weeks of treatment 9
• Reactions occurring more than 3 months after starting therapy are almost always due to another cause, not the SSRI itself, as stated by the British Journal of Pharmacology 7
• True allergic reactions are reproducible, dose-independent phenomena that resolve with drug discontinuation, according to the Annals of Oncology 8

Risk Assessment and Monitoring

• Monitor patients most carefully during weeks 1-3 of fluoxetine therapy, as this represents the highest-risk period for developing delayed hypersensitivity reactions 6, 7

Anaphylaxis Mechanisms and Reactions

Understanding IgE-Mediated Anaphylaxis

• The European Academy of Allergy and Clinical Immunology (EAACI) clarifies that "allergic anaphylaxis" should only be used when the reaction is mediated by an immunological mechanism such as IgE, IgG, or complement activation, and an IgE-mediated anaphylactic reaction is specifically termed "IgE-mediated allergic anaphylaxis" 10, 11, 12
• IgE-mediated reactions represent one mechanism of anaphylactic shock, occurring when allergen exposure triggers mast cell and basophil activation through IgE receptor cross-linking 10, 11

Non-IgE Mechanisms Can Also Cause Anaphylactic Shock

• Anaphylatoxin activation (complement-mediated) can cause anaphylactic shock through non-IgE pathways that produce clinically identical presentations 10, 11
• The term "anaphylactoid" was previously used for non-IgE-mediated reactions but is no longer recommended by EAACI, though American guidelines still use this terminology 10, 11, 12

Common Pitfalls

• Beta-blockers and ACE inhibitors increase the risk of severe anaphylactic reactions and reduce epinephrine effectiveness, regardless of the underlying mechanism 10, 11
• Radiographic contrast material reactions are clinically identical to IgE-mediated anaphylaxis but typically occur through non-immunologic mechanisms 13

Management of Fluoxetine‑Induced Cutaneous Reactions

Mild, Isolated Cutaneous Reactions

• In patients who develop a mild, isolated rash while taking fluoxetine, stopping the medication and providing moderate‑potency topical corticosteroids, daytime non‑sedating antihistamines, nighttime sedating antihistamines, regular emollient application, and avoiding hot showers or harsh soaps results in prompt symptom relief and an expected full recovery. 14

Warning Signs of Severe Reactions

• The appearance of fever together with a rash in a patient receiving fluoxetine should raise concern for serious cutaneous adverse events such as DRESS syndrome and warrants urgent clinical evaluation. 14

• When blisters, skin peeling, mucosal erosions, or other manifestations of severe hypersensitivity occur in a patient on fluoxetine, the drug must be discontinued immediately and should not be re‑initiated. 15